Last I heard Leqembi has been shown to reduce the amyloid plaques characteristic of Alzheimer's, but has not been shown to have an actual impact on disease progression. Is that still the case?
Much more when it is your last month or two of lucidity.
Nobody will be too surprised if the medicine will be retracted, as it was a very controversial approval process.